However, age-adjusted PSA ranges, PSA velocity, PSA density, and free PSA fraction have all been disappointing in their ability to discriminate between BPH and prostate cancer [16], making it very difficult to differentiate between these two diseases in a clinical setting. Here, KLK3 is linked to benign prostatic hyperplasia.